130 related articles for article (PubMed ID: 22607697)
21. Nanomolar competitive inhibitors of Mycobacterium tuberculosis and Streptomyces coelicolor type II dehydroquinase.
Prazeres VF; Sánchez-Sixto C; Castedo L; Lamb H; Hawkins AR; Riboldi-Tunnicliffe A; Coggins JR; Lapthorn AJ; González-Bello C
ChemMedChem; 2007 Feb; 2(2):194-207. PubMed ID: 17245805
[TBL] [Abstract][Full Text] [Related]
22. Studies on the nitroreductase prodrug-activating system. Crystal structures of complexes with the inhibitor dicoumarol and dinitrobenzamide prodrugs and of the enzyme active form.
Johansson E; Parkinson GN; Denny WA; Neidle S
J Med Chem; 2003 Sep; 46(19):4009-20. PubMed ID: 12954054
[TBL] [Abstract][Full Text] [Related]
23. Investigation of potential inhibitors of chorismate-utilizing enzymes.
Švarcová M; Krátký M; Vinšova J
Curr Med Chem; 2015; 22(11):1383-99. PubMed ID: 25666801
[TBL] [Abstract][Full Text] [Related]
24. A prodrug approach for improving antituberculosis activity of potent Mycobacterium tuberculosis type II dehydroquinase inhibitors.
Tizón L; Otero JM; Prazeres VF; Llamas-Saiz AL; Fox GC; van Raaij MJ; Lamb H; Hawkins AR; Ainsa JA; Castedo L; González-Bello C
J Med Chem; 2011 Sep; 54(17):6063-84. PubMed ID: 21780742
[TBL] [Abstract][Full Text] [Related]
25. Structural analysis of mycobacterial branched-chain aminotransferase: implications for inhibitor design.
Castell A; Mille C; Unge T
Acta Crystallogr D Biol Crystallogr; 2010 May; 66(Pt 5):549-57. PubMed ID: 20445230
[TBL] [Abstract][Full Text] [Related]
26. Crystal structures of cystathionine gamma-synthase inhibitor complexes rationalize the increased affinity of a novel inhibitor.
Steegborn C; Laber B; Messerschmidt A; Huber R; Clausen T
J Mol Biol; 2001 Aug; 311(4):789-801. PubMed ID: 11518531
[TBL] [Abstract][Full Text] [Related]
27. Structural Study of a New MbtI-Inhibitor Complex: Towards an Optimized Model for Structure-Based Drug Discovery.
Mori M; Villa S; Chiarelli LR; Meneghetti F; Bellinzoni M
Pharmaceuticals (Basel); 2023 Nov; 16(11):. PubMed ID: 38004425
[TBL] [Abstract][Full Text] [Related]
28. Discovery of an acyclic nucleoside phosphonate that inhibits Mycobacterium tuberculosis ThyX based on the binding mode of a 5-alkynyl substrate analogue.
Parchina A; Froeyen M; Margamuljana L; Rozenski J; De Jonghe S; Briers Y; Lavigne R; Herdewijn P; Lescrinier E
ChemMedChem; 2013 Aug; 8(8):1373-83. PubMed ID: 23836539
[TBL] [Abstract][Full Text] [Related]
29. Structural and thermodynamic insights into the binding mode of five novel inhibitors of lumazine synthase from Mycobacterium tuberculosis.
Morgunova E; Illarionov B; Sambaiah T; Haase I; Bacher A; Cushman M; Fischer M; Ladenstein R
FEBS J; 2006 Oct; 273(20):4790-804. PubMed ID: 16984393
[TBL] [Abstract][Full Text] [Related]
30. Inhibition studies on salicylate synthase.
Payne RJ; Kerbarh O; Miguel RN; Abell AD; Abell C
Org Biomol Chem; 2005 May; 3(10):1825-7. PubMed ID: 15889161
[TBL] [Abstract][Full Text] [Related]
31. Structure of isocitrate lyase, a persistence factor of Mycobacterium tuberculosis.
Sharma V; Sharma S; Hoener zu Bentrup K; McKinney JD; Russell DG; Jacobs WR; Sacchettini JC
Nat Struct Biol; 2000 Aug; 7(8):663-8. PubMed ID: 10932251
[TBL] [Abstract][Full Text] [Related]
32. Synthesis of various 3-nitropropionamides as Mycobacterium tuberculosis isocitrate lyase inhibitor.
Sriram D; Yogeeswari P; Methuku S; Vyas DR; Senthilkumar P; Alvala M; Jeankumar VU
Bioorg Med Chem Lett; 2011 Sep; 21(18):5149-54. PubMed ID: 21840711
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis, and evaluation of 9-D-ribitylamino-1,3,7,9-tetrahydro-2,6,8-purinetriones bearing alkyl phosphate and alpha,alpha-difluorophosphonate substituents as inhibitors of tiboflavin synthase and lumazine synthase.
Cushman M; Sambaiah T; Jin G; Illarionov B; Fischer M; Bacher A
J Org Chem; 2004 Feb; 69(3):601-12. PubMed ID: 14750781
[TBL] [Abstract][Full Text] [Related]
34. The molecular structure of ornithine acetyltransferase from Mycobacterium tuberculosis bound to ornithine, a competitive inhibitor.
Sankaranarayanan R; Cherney MM; Garen C; Garen G; Niu C; Yuan M; James MN
J Mol Biol; 2010 Apr; 397(4):979-90. PubMed ID: 20184895
[TBL] [Abstract][Full Text] [Related]
35. The structure of 3-deoxy-d-arabino-heptulosonate 7-phosphate synthase from Mycobacterium tuberculosis reveals a common catalytic scaffold and ancestry for type I and type II enzymes.
Webby CJ; Baker HM; Lott JS; Baker EN; Parker EJ
J Mol Biol; 2005 Dec; 354(4):927-39. PubMed ID: 16288916
[TBL] [Abstract][Full Text] [Related]
36. Structural and thermodynamic study on aldose reductase: nitro-substituted inhibitors with strong enthalpic binding contribution.
Steuber H; Heine A; Klebe G
J Mol Biol; 2007 May; 368(3):618-38. PubMed ID: 17368668
[TBL] [Abstract][Full Text] [Related]
37. Molecular recognition at the active site of catechol-O-methyltransferase (COMT): adenine replacements in bisubstrate inhibitors.
Ellermann M; Paulini R; Jakob-Roetne R; Lerner C; Borroni E; Roth D; Ehler A; Schweizer WB; Schlatter D; Rudolph MG; Diederich F
Chemistry; 2011 May; 17(23):6369-81. PubMed ID: 21538606
[TBL] [Abstract][Full Text] [Related]
38. T-state inhibitors of E. coli aspartate transcarbamoylase that prevent the allosteric transition.
Heng S; Stieglitz KA; Eldo J; Xia J; Cardia JP; Kantrowitz ER
Biochemistry; 2006 Aug; 45(33):10062-71. PubMed ID: 16906764
[TBL] [Abstract][Full Text] [Related]
39. The three-dimensional structure of N-succinyldiaminopimelate aminotransferase from Mycobacterium tuberculosis.
Weyand S; Kefala G; Weiss MS
J Mol Biol; 2007 Mar; 367(3):825-38. PubMed ID: 17292400
[TBL] [Abstract][Full Text] [Related]
40. Structure-based design of a potent and selective small peptide inhibitor of Mycobacterium tuberculosis 6-hydroxymethyl-7, 8-dihydropteroate synthase: a computer modelling approach.
Rao GS; Kumar M
Chem Biol Drug Des; 2008 Jun; 71(6):540-5. PubMed ID: 18482337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
